New Pharmacovigilance Legislation in the Eu

被引：0

作者：

Farzan, J. ^{[1
]}

机构：

[1] Paul Ehrlich Inst, D-63225 Langen, Germany

来源：

PSYCHOPHARMAKOTHERAPIE | 2011年 / 18卷 / 06期

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：267 / 269

页数：3

共 50 条

[1] New EU pharmacovigilance legislation enacted
Reactions Weekly, 2012, 1409 (1) : 2 - 2
[2] Strengthening and Rationalizing Pharmacovigilance in the EU: Where is Europe Heading to?A Review of the New EU Legislation on Pharmacovigilance
John-Joseph Borg
George Aislaitner
Michal Pirozynski
Stephen Mifsud
Drug Safety, 2011, 34 : 187 - 197
[3] Strengthening and Rationalizing Pharmacovigilance in the EU: Where is Europe Heading to? A Review of the New EU Legislation on Pharmacovigilance
Borg, John-Joseph
Aislaitner, George
Pirozynski, Michal
Mifsud, Stephen
DRUG SAFETY, 2011, 34 (03) : 187 - 197
[4] EU's New Pharmacovigilance Legislation: Considerations for Biosimilars
Calvo, Begona
Zuniga, Leyre
DRUG SAFETY, 2014, 37 (01) : 9 - 18
[5] EU’s New Pharmacovigilance Legislation: Considerations for Biosimilars
Begoña Calvo
Leyre Zuñiga
Drug Safety, 2014, 37 : 9 - 18
[6] Comment On: "EU's New Pharmacovigilance Legislation: Considerations for Biosimilars"
Borg, John Joseph
Serracino-Inglott, Anthony
Azzopardi, Lilian M.
Schneider, Christian K.
DRUG SAFETY, 2014, 37 (02) : 123 - 124
[7] Comment On: “EU’s New Pharmacovigilance Legislation: Considerations for Biosimilars”
John Joseph Borg
Anthony Serracino-Inglott
Lilian M. Azzopardi
Christian K. Schneider
Drug Safety, 2014, 37 : 123 - 124
[8] The New EU Legislation on Pharmacovigilance and Changing Models for Drug Development
Torbjörn Callréus
Drug Safety, 2011, 34 : 529 - 530
[9] The New EU Legislation on Pharmacovigilance and Changing Models for Drug Development
Callreus, Torbjorn
DRUG SAFETY, 2011, 34 (06) : 529 - 530
[10] EU’s new pharmacovigilance legislation: first EMA report
Reactions Weekly, 2014, 1501 (1) : 4 - 4

← 1 2 3 4 5 →